SEC: Trading scheme involved confidential government information

The Securities and Exchange Commission has announced alleged insider-trading charges in a plot that used non-public government information to affect the value of publicly traded medical stocks.

WELCOME TO OUR OPEN HOUSE – LOG IN TO CONTINUE READING FOR FREE

If you are already a registered user or a member, SIGN IN now.